Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study.

Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G.

Int J Impot Res. 2007 Mar-Apr;19(2):200-7.

PMID:
16943794
2.

[Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil].

Porst H, Hell-Momeni K, Büttner H.

Urologe A. 2009 Nov;48(11):1318, 1320-9. doi: 10.1007/s00120-009-2089-y. Review. German.

PMID:
19756466
3.

A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition.

Fusco F, Razzoli E, Imbimbo C, Rossi A, Verze P, Mirone V.

BJU Int. 2010 Jun;105(12):1634-9. doi: 10.1111/j.1464-410X.2010.09244.x. Review.

4.

[Evaluation of tadalafil for the treatment of erectile dysfunction].

Liu ZY, Sun YH.

Zhonghua Nan Ke Xue. 2008 Apr;14(4):377-80. Review. Chinese.

PMID:
18481436
5.

Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited.

Aversa A, Bruzziches R, Spera G.

Int J Androl. 2005 Dec;28 Suppl 2:61-3. Review.

PMID:
16236067
6.

[Pharmacological, pharmacokinetic, and clinical profile of tadalafil (Cialis)].

Yamaguchi T, Uenaka K, Imaoka T.

Nihon Yakurigaku Zasshi. 2008 Jun;131(6):469-77. Review. Japanese. No abstract available.

PMID:
18552451
7.
8.

Relation of endothelial cell function to erectile dysfunction: implications for treatment.

Guay AT.

Am J Cardiol. 2005 Dec 26;96(12B):52M-56M. Review.

PMID:
16387568
9.

Can phosphodiesterase type 5 inhibitors cure erectile dysfunction?

Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL.

Eur Urol. 2006 Jun;49(6):979-86. Review.

PMID:
16431013
10.

Endothelial function and its assessment.

Felmeden DC, Lip GY.

Expert Opin Investig Drugs. 2005 Nov;14(11):1319-36. Review.

PMID:
16255673
11.

Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH.

Panminerva Med. 2010 Jun;52(2 Suppl 1):75-80. Review.

PMID:
20657539
12.

Erectile dysfunction in diabetic patients.

Chaiban JT, Azar ST.

J Med Liban. 2004 Oct-Dec;52(4):217-9. Review.

PMID:
16432985
13.

Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis.

Santi D, Giannetta E, Isidori AM, Vitale C, Aversa A, Simoni M.

Eur J Endocrinol. 2015 Mar;172(3):R103-14. doi: 10.1530/EJE-14-0700. Review.

14.

Chronic antioxidant use and changes in endothelial dysfunction: a review of clinical investigations.

Aminbakhsh A, Mancini J.

Can J Cardiol. 1999 Aug;15(8):895-903. Review. English, French.

PMID:
10446437
15.

[The endothelial dysfunction as one of the possible causes of emergence and progression of chronic venous insufficiency of lower extremities].

Stoĭko IuM, Lytkin MI, Shaĭdakov EV, Gavrilov EK.

Vestn Khir Im I I Grek. 2004;163(2):122-7. Review. Russian. No abstract available.

PMID:
15199789
Items per page

Supplemental Content

Support Center